Evidence map›Paper›PMID 39635280›Full record

ReviewNanophotonics (Berlin, Germany)2022

Recent progress in terahertz metamaterial modulators.

Riccardo Degl'Innocenti, Hungyen Lin, Miguel Navarro-Cía

Abstract readReview
In one paragraph

Review in Nanophotonics (Berlin, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Terahertz frequency electronics and photonics: materials and devices.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Analysis of the response mechanisms ofFrontiers in plant science · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Riccardo Degl'InnocentiDepartment of Engineering, University of Lancaster, Bailrigigg, Lancaster LA1 4YW, UK.ORCID https://orcid.org/0000-0003-2655-1997
Hungyen LinDepartment of Engineering, University of Lancaster, Bailrigigg, Lancaster LA1 4YW, UK.
Miguel Navarro-CíaSchool of Physics and Astronomy, University of Birmingham, B15 2TT Birmingham, UK.ORCID https://orcid.org/0000-0003-0256-6465

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The terahertz (0.1-10 THz) range represents a fast-evolving research and industrial field. The great interest for this portion of the electromagnetic spectrum, which lies between the photonics and the electronics ranges, stems from the unique and disruptive sectors where this radiation finds applications in, such as spectroscopy, quantum electronics, sensing and wireless communications beyond 5G. Engineering the propagation of terahertz light has always proved to be an intrinsically difficult task and for a long time it has been the bottleneck hindering the full exploitation of the terahertz spectrum. Amongst the different approaches that have been proposed so far for terahertz signal manipulation, the implementation of metamaterials has proved to be the most successful one, owing to the relative ease of realisation, high efficiency and spectral versatility. In this review, we present the latest developments in terahertz modulators based on metamaterials, while highlighting a few selected key applications in sensing, wireless communications and quantum electronics, which have particularly benefitted from these developments.

Indexed as

metamaterialsmodulatorsterahertz

Identifiers

PMID39635280
PMCPMC11501865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.